We have previously demonstrated that blockade of PD-1 receptor in combination with STEAP1 heterologous vaccination enhances efficacy and significantly improves survival of mice in the TRAMP-C1 subcutaneous tumour model [17]. This evidence concerns the gene STEAP1 and neoplasm.